Drugs / IGN-ES001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03058224 | Feb → Nov 2017 | fibromyalgia | IgNova GmbH | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IGN-ES001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03058224 ↗ |